Myth or Fact: Summer Health Edition

Amy McMichael, MD, explains that access to dermatologists in communities of color is limited, contributing to delays in proper psoriasis diagnosis and care.

April Armstrong, MD, MPH, discusses the National Psoriasis Foundation’s recent initiatives, including their partnership with Amgen, and emphasizes the importance of education and support for patients.

Even after psoriasis skin symptoms are well controlled with biologics, more than one-third of patients still have hidden inflammation that raises their risk for heart disease.

Most skin cancers are preventable and treatable when caught early — Elizabeth Hale, M.D., explains why daily SPF and annual skin checks are essential.

An overview of what you need to know and how to protect yourself for Skin Cancer Awareness Month.

Rosacea significantly impacts quality of life, anxiety and depression compared with healthy individuals.

Most participants undergoing the laser treatment reported long-lasting positive effects with minimal adverse events.

Linda Stein Gold, M.D., highlights how the SPECTREM study demonstrates guselkumab’s ability to achieve significant skin clearance and improve quality of life in patients with psoriasis affecting sensitive, hard-to-treat areas.

Patients with acne, especially moderate to severe cases, have a higher risk of gastrointestinal issues, suggesting the need for integrated care between dermatology and gastroenterology.

Jennifer Hsiao, M.D., emphasizes the importance of early diagnosis and tailored treatment for hidradenitis suppurativa to reduce its impact on quality of life and prevent severe complications.

Uwe Gudat, M.D., explains how recent phase 3 data confirm the biosimilarity and interchangeability of adalimumab-fkjp and Bmab 1200 with their bio-originals, providing assurance to patients with chronic plaque psoriasis.

Stephanie Manson Brown, MBBS, MRCS, MFPM, discusses Allergan Aesthetics’ mission to promote diversity, empowering patients to celebrate their unique beauty.

Stephanie Manson Brown, MBBS, MRCS, MFPM, advocates for aesthetic treatments and initiatives that cater to diverse skin types.

Amy McMichael, MD, highlights the success of the VISIBLE trial, proving that biologics significantly improve psoriasis outcomes in skin of color.

Amy McMichael, MD, explains that access to dermatologists in communities of color is limited, contributing to delays in proper psoriasis diagnosis and care.

April Armstrong, MD, MPH, discusses the National Psoriasis Foundation’s recent initiatives, including their partnership with Amgen, and emphasizes the importance of education and support for patients.